These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25302696)

  • 41. Qualitative High-Throughput Analysis of Subvisible Particles in Biological Formulations Using Backgrounded Membrane Imaging.
    Murphy MI; Bruque M; Hanford A; Trayton I; Handali M; Leissa JA; Hasige S; Day K; Patel SM
    J Pharm Sci; 2022 Jun; 111(6):1605-1613. PubMed ID: 35318031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy.
    Narhi LO; Corvari V; Ripple DC; Afonina N; Cecchini I; Defelippis MR; Garidel P; Herre A; Koulov AV; Lubiniecki T; Mahler HC; Mangiagalli P; Nesta D; Perez-Ramirez B; Polozova A; Rossi M; Schmidt R; Simler R; Singh S; Spitznagel TM; Weiskopf A; Wuchner K
    J Pharm Sci; 2015 Jun; 104(6):1899-1908. PubMed ID: 25832583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Water Proton NMR: A Tool for Protein Aggregation Characterization.
    Taraban MB; DePaz RA; Lobo B; Yu YB
    Anal Chem; 2017 May; 89(10):5494-5502. PubMed ID: 28440620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of different analytical methods for the characterization of non-spherical micro- and nanoparticles.
    Mathaes R; Winter G; Engert J; Besheer A
    Int J Pharm; 2013 Sep; 453(2):620-9. PubMed ID: 23727141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flow Microscopy Imaging Is Sensitive to Characteristics of Subvisible Particles in Peginesatide Formulations Associated With Severe Adverse Reactions.
    Daniels AL; Randolph TW
    J Pharm Sci; 2018 May; 107(5):1313-1321. PubMed ID: 29409840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flow imaging: moving toward best practices for subvisible particle quantitation in protein products.
    Wilson GA; Manning MC
    J Pharm Sci; 2013 Mar; 102(3):1133-4. PubMed ID: 23303598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of Flow Imaging Analysis for Subvisible Particle Characterization in Glatiramer Acetate.
    Levin I; Zigman S; Komlosh A; Kettenring J
    J Pharm Sci; 2015 Nov; 104(11):3977-3983. PubMed ID: 26099719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of the Density of Protein Particles Using a Suspended Microchannel Resonator.
    Folzer E; Khan TA; Schmidt R; Finkler C; Huwyler J; Mahler HC; Koulov AV
    J Pharm Sci; 2015 Dec; 104(12):4034-4040. PubMed ID: 26344825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of Average Aggregate Density from Stir-Stressed NISTmAb Protein.
    Cavicchi RE; Philips LA; Cheong FC; Ruffner DB; Kasimbeg P; Vreeland W
    J Pharm Sci; 2022 Jun; 111(6):1614-1624. PubMed ID: 35318032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitation of protein particles in parenteral solutions using micro-flow imaging.
    Huang CT; Sharma D; Oma P; Krishnamurthy R
    J Pharm Sci; 2009 Sep; 98(9):3058-71. PubMed ID: 18937372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
    Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
    J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No Touching! Abrasion of Adsorbed Protein Is the Root Cause of Subvisible Particle Formation During Stirring.
    Sediq AS; van Duijvenvoorde RB; Jiskoot W; Nejadnik MR
    J Pharm Sci; 2016 Feb; 105(2):519-529. PubMed ID: 26869415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Use of a GroEL-BLI Biosensor to Rapidly Assess Preaggregate Populations for Antibody Solutions Exhibiting Different Stability Profiles.
    Pace SE; Joshi SB; Esfandiary R; Stadelman R; Bishop SM; Middaugh CR; Fisher MT; Volkin DB
    J Pharm Sci; 2018 Feb; 107(2):559-570. PubMed ID: 29037466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Collaborative Study for Analysis of Subvisible Particles Using Flow Imaging and Light Obscuration: Experiences in Japanese Biopharmaceutical Consortium.
    Kiyoshi M; Shibata H; Harazono A; Torisu T; Maruno T; Akimaru M; Asano Y; Hirokawa M; Ikemoto K; Itakura Y; Iwura T; Kikitsu A; Kumagai T; Mori N; Murase H; Nishimura H; Oda A; Ogawa T; Ojima T; Okabe S; Saito S; Saitoh S; Suetomo H; Takegami K; Takeuchi M; Yasukawa H; Uchiyama S; Ishii-Watabe A
    J Pharm Sci; 2019 Feb; 108(2):832-841. PubMed ID: 30121316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigations into the fouling mechanism of parvovirus filters during filtration of freeze-thawed mAb drug substance solutions.
    Barnard JG; Kahn D; Cetlin D; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Mar; 103(3):890-9. PubMed ID: 24549732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Subvisible Particles in Biopharmaceutical Formulations Using Raman Spectroscopy Provides Insight into Polysorbate 20 Degradation Pathway.
    Saggu M; Liu J; Patel A
    Pharm Res; 2015 Sep; 32(9):2877-88. PubMed ID: 25773722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of submicron particles on formation of micron-sized particles during long-term storage of an interferon-β-1a solution.
    Bai S; Murugesan Y; Vlasic M; Karpes LB; Brader ML
    J Pharm Sci; 2013 Feb; 102(2):347-51. PubMed ID: 23233283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors Governing the Precision of Subvisible Particle Measurement Methods - A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled Syringe.
    Ríos Quiroz A; Lamerz J; Da Cunha T; Boillon A; Adler M; Finkler C; Huwyler J; Schmidt R; Mahler HC; Koulov AV
    Pharm Res; 2016 Feb; 33(2):450-61. PubMed ID: 26474763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subvisible Particle Analysis of 17 Monoclonal Antibodies Approved in China Using Flow Imaging and Light Obscuration.
    Guo S; Yu C; Guo X; Jia Z; Yu X; Yang Y; Guo L; Wang L
    J Pharm Sci; 2022 Apr; 111(4):1164-1171. PubMed ID: 34551350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microparticles and Nanoparticles Delivered in Intravenous Saline and in an Intravenous Solution of a Therapeutic Antibody Product.
    Pardeshi NN; Qi W; Dahl K; Caplan L; Carpenter JF
    J Pharm Sci; 2017 Feb; 106(2):511-520. PubMed ID: 27832839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.